Cybin (HELP) Current Leases (2023 - 2024)
Cybin (HELP) reported Current Leases of $97496.1 for Q3 2024, down 37.1% quarter-over-quarter from $155001.8 in Q2 2024.
Cybin (HELP) Current Leases (2023 - 2024) Analysis & Trends
Cybin has reported Current Leases for 2 years, with the latest figure at $97496.1 in Q3 2024.
- For the quarter ending Q3 2024, Current Leases changed N/A year-over-year to $97496.1; the trailing twelve-month figure through Sep 2024 stood at $97496.1 (changed N/A YoY), and the FY2024 full-year result was $215954.9, changed N/A from the prior year.
- Current Leases for Q3 2024 stood at $97496.1, down from $155001.8 in the prior quarter.
- The five-year high for Current Leases was $237989.5 in Q4 2023, with the low at $97496.1 in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 42,980.09 |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 83,991.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 7.40 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Cybin | 75.42 Mn | 75.42 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | 97,496.10 |
| Jun 30, 2024 | 155,001.80 |
| Mar 31, 2024 | 215,954.94 |
| Dec 31, 2023 | 237,989.51 |
| Jun 30, 2023 | 234,502.53 |
| Feb 28, 2023 | 226,867.54 |